Earnings summaries and quarterly performance for CROSS COUNTRY HEALTHCARE.
Executive leadership at CROSS COUNTRY HEALTHCARE.
John Martins
President and Chief Executive Officer
Colin McDonald
Chief Human Resources Officer
Cynthia Grieco
Vice President, Corporate Treasurer
James Redd
Chief Accounting Officer
Karen Mote
President, Cross Country Locums
Marc Krug
Group President
Phillip Noe
Chief Information Officer
Susan Ball
Executive Vice President, Chief Administrative Officer, General Counsel and Secretary
William Burns
Executive Vice President, Chief Financial Officer
Board of directors at CROSS COUNTRY HEALTHCARE.
Research analysts who have asked questions during CROSS COUNTRY HEALTHCARE earnings calls.
Constantine Davides
Citizens JMP
7 questions for CCRN
Trevor Romeo
William Blair
7 questions for CCRN
Albert Rice
UBS
5 questions for CCRN
Brian Tanquilut
Jefferies
5 questions for CCRN
Tobey Sommer
Truist Securities, Inc.
5 questions for CCRN
William Sutherland
The Benchmark Company
5 questions for CCRN
Kevin Steinke
Barrington Research
4 questions for CCRN
Jack Slevin
Jefferies Financial Group Inc.
2 questions for CCRN
Jasper Bibb
Truist Securities
2 questions for CCRN
Kevin Fischbeck
Bank of America
2 questions for CCRN
A.J. Rice
UBS Group AG
1 question for CCRN
Bill Sutherland
The Benchmark Company LLC
1 question for CCRN
Recent press releases and 8-K filings for CCRN.
- John A. Martins has separated from Cross Country Healthcare as President and Chief Executive Officer and ceased to serve as a member of its Board of Directors, effective December 14, 2025.
- Kevin C. Clark, the Company's Co-Founder and current Chairman, has been appointed to succeed Mr. Martins as President and Chief Executive Officer.
- Mr. Clark previously served as CEO from 1986 to 1994 and again from 2019 to 2022, periods which resulted in rapid growth and strong financial results.
- The Board believes the CEO transition is appropriate following the termination of the transaction with Aya Healthcare.
- Mr. Clark plans to lead the company into a new era of innovative AI-led, tech-enabled workforce solutions, focusing on sharpening focus, reducing costs, and optimizing capital allocation to drive sustainable, long-term profitable growth.
- Cross Country Healthcare reported consolidated revenue of $250.1 million for the third quarter ended September 30, 2025, representing a 21% decrease year-over-year and a 9% sequential decrease. The company posted a net loss attributable to common stockholders of $(4.8) million and diluted EPS of $(0.15) for the quarter.
- Adjusted EBITDA for Q3 2025 was $6.5 million, or 2.6% of revenue, and Adjusted EPS was $0.03.
- As of September 30, 2025, the company maintained a strong balance sheet with $99 million of cash on-hand and no debt outstanding, generating $20.1 million in cash flows from operations during the quarter.
- The pending merger with Aya Healthcare is awaiting the expiration of the HSR waiting period, which was set to expire on November 17, 2025 but has been extended due to a government shutdown. The merger end date was extended to December 3, 2025, and the company is currently discussing a further extension.
- Cross Country Healthcare reported Q3 2025 revenue of $250.1 million, a 21% year-over-year decrease, resulting in a net loss of $(4.8) million and diluted EPS of $(0.15).
- Despite revenue declines, the company generated $20.1 million in positive cash flow from operations and maintained a strong balance sheet with $99.1 million in cash and no debt as of September 30, 2025.
- Homecare Staffing revenue grew over 29% year-over-year, and the company secured more than $400 million in new or renewed contract value.
- The pending merger with Aya Healthcare is subject to FTC review, with the HSR waiting period extended due to a government shutdown, potentially requiring an extension beyond the current December 3, 2025 merger end date.
Quarterly earnings call transcripts for CROSS COUNTRY HEALTHCARE.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more